pd 169316 has been researched along with pyrazolanthrone in 9 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 7 (77.78) | 29.6817 |
| 2010's | 2 (22.22) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bullock, AN; Fedorov, O; Knapp, S; Marsden, B; Müller, S; Pogacic, V; Rellos, P; Schwaller, J; Sundström, M | 1 |
| Austin, CP; Fidock, DA; Hayton, K; Huang, R; Inglese, J; Jiang, H; Johnson, RL; Su, XZ; Wellems, TE; Wichterman, J; Yuan, J | 1 |
| Augustin, M; Davies, SP; Gao, Y; Harvey, KJ; Kovelman, R; Patel, UA; Woodward, A | 1 |
| Srikant, CB; Tourian, L; Zhao, H | 1 |
| Harada, A; Kato, K; Kozawa, O; Matsushima-Nishiwaki, R; Takai, S; Tokuda, H; Yasuda, E; Yoshida, M | 1 |
| Montesano, R | 1 |
| Carmona-Cuenca, I; Del Castillo, G; Fabregat, I; Fernández, M; Murillo, MM; Ortiz, C; Roncero, C; Sánchez, A | 1 |
| Carrozzino, F; Féraille, E; Montesano, R; Pugnale, P | 1 |
| Dey, CS; Mukhopadhyay, AG; Reddy, GS | 1 |
9 other study(ies) available for pd 169316 and pyrazolanthrone
| Article | Year |
|---|---|
A systematic interaction map of validated kinase inhibitors with Ser/Thr kinases.
Topics: Amino Acid Sequence; Binding Sites; Clinical Trials as Topic; Drug Evaluation, Preclinical; Enzyme Stability; Humans; Molecular Sequence Data; Phylogeny; Protein Array Analysis; Protein Conformation; Protein Kinase Inhibitors; Protein Serine-Threonine Kinases | 2007 |
Genetic mapping of targets mediating differential chemical phenotypes in Plasmodium falciparum.
Topics: Animals; Antimalarials; ATP Binding Cassette Transporter, Subfamily B, Member 1; Chromosome Mapping; Crosses, Genetic; Dihydroergotamine; Drug Design; Drug Resistance; Humans; Inhibitory Concentration 50; Mutation; Plasmodium falciparum; Quantitative Trait Loci; Transfection | 2009 |
A broad activity screen in support of a chemogenomic map for kinase signalling research and drug discovery.
Topics: Aurora Kinases; Cluster Analysis; Drug Design; Drug Discovery; Drug Evaluation, Preclinical; ErbB Receptors; Humans; Intracellular Signaling Peptides and Proteins; MAP Kinase Kinase 4; p38 Mitogen-Activated Protein Kinases; Protein Kinase Inhibitors; Protein Kinases; Protein Serine-Threonine Kinases; Protein-Tyrosine Kinases; Receptors, Vascular Endothelial Growth Factor; Recombinant Proteins; Reproducibility of Results; Signal Transduction; Small Molecule Libraries; Structure-Activity Relationship; Syk Kinase | 2013 |
p38alpha, but not p38beta, inhibits the phosphorylation and presence of c-FLIPS in DISC to potentiate Fas-mediated caspase-8 activation and type I apoptotic signaling.
Topics: Anthracenes; Antibodies, Monoclonal; Apoptosis; bcl-2-Associated X Protein; bcl-Associated Death Protein; Carrier Proteins; CASP8 and FADD-Like Apoptosis Regulating Protein; Caspase 8; Caspases; Death Domain Receptor Signaling Adaptor Proteins; Enzyme Activation; Enzyme Inhibitors; fas Receptor; Humans; Imidazoles; Immunoblotting; Intracellular Signaling Peptides and Proteins; Isoenzymes; Jurkat Cells; Membrane Potentials; Mitochondria; p38 Mitogen-Activated Protein Kinases; Phosphorylation; Precipitin Tests; Proto-Oncogene Proteins c-bcl-2; Proto-Oncogene Proteins c-jun; Receptors, Tumor Necrosis Factor | 2004 |
Prostaglandin D2 induces the phosphorylation of HSP27 in osteoblasts: function of the MAP kinase superfamily.
Topics: Animals; Anthracenes; Cell Line; Enzyme Inhibitors; Flavonoids; Heat-Shock Proteins; Imidazoles; Intracellular Signaling Peptides and Proteins; Mice; Mitogen-Activated Protein Kinases; Osteoblasts; Phosphorylation; Prostaglandin D2; Protein Kinases; Protein Serine-Threonine Kinases | 2006 |
Bone morphogenetic protein-4 abrogates lumen formation by mammary epithelial cells and promotes invasive growth.
Topics: Animals; Anthracenes; Bone Morphogenetic Protein 4; Bone Morphogenetic Proteins; Butadienes; Cell Transformation, Neoplastic; Cells, Cultured; Epithelial Cells; Female; Humans; Imidazoles; Mammary Glands, Animal; Mice; Mitogen-Activated Protein Kinases; Neoplasm Invasiveness; Nitriles | 2007 |
Activation of NADPH oxidase by transforming growth factor-beta in hepatocytes mediates up-regulation of epidermal growth factor receptor ligands through a nuclear factor-kappaB-dependent mechanism.
Topics: Acetophenones; Animals; Anthracenes; Benzamides; Chromones; Dioxoles; Enzyme Activation; Epidermal Growth Factor; ErbB Receptors; Extracellular Signal-Regulated MAP Kinases; Flavonoids; Heparin-binding EGF-like Growth Factor; Hepatocytes; Humans; Imidazoles; Intercellular Signaling Peptides and Proteins; Morpholines; NADH, NADPH Oxidoreductases; NADPH Oxidase 1; NADPH Oxidase 4; NADPH Oxidases; NF-kappa B; Onium Compounds; Peptides; Phosphatidylinositol 3-Kinases; Proto-Oncogene Proteins c-akt; Quinazolines; rac1 GTP-Binding Protein; Rats; Reactive Oxygen Species; Transforming Growth Factor beta; Tyrphostins; Up-Regulation | 2007 |
Inhibition of basal p38 or JNK activity enhances epithelial barrier function through differential modulation of claudin expression.
Topics: Animals; Anthracenes; Butadienes; Cell Line; Dogs; Epithelium; Female; Imidazoles; Mammary Glands, Animal; MAP Kinase Kinase 4; Membrane Proteins; Mice; Nitriles; p38 Mitogen-Activated Protein Kinases | 2009 |
The p38 MAP kinase inhibitor, PD 169316, inhibits flagellar motility in Leishmania donovani.
Topics: Animals; Anisomycin; Anthracenes; Flagella; Flavonoids; Imidazoles; Leishmania donovani; MAP Kinase Signaling System; Microscopy, Video; Movement; p38 Mitogen-Activated Protein Kinases; Protein Kinase Inhibitors; Protozoan Proteins | 2017 |